It was reported that after a procedure to implant this patient with a new cardiac resynchronization therapy defibrillator (crt-d), the patient presented for follow up and was having symptoms of shortness of breath.There was no left ventricular (lv) capture with this lead, and there was an issue with sensing.It was suspected that the leads were reversed in the header.A surgical revision was performed, and it was confirmed that this lv lead and the non-boston scientific right atrial lead were reversed in the header.This was corrected with no further issues.No additional adverse patient effects were reported.The lead remains in service.
|